Divergent Planning LLC bought a new stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,048 shares of the company's stock, valued at approximately $486,000.
Other institutional investors also recently modified their holdings of the company. Nova Wealth Management Inc. bought a new position in Procter & Gamble in the 1st quarter valued at approximately $26,000. Signature Resources Capital Management LLC increased its position in Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock valued at $28,000 after acquiring an additional 72 shares during the period. Quarry LP bought a new position in shares of Procter & Gamble during the first quarter valued at $33,000. Mid American Wealth Advisory Group Inc. bought a new position in shares of Procter & Gamble during the second quarter valued at $34,000. Finally, RMG Wealth Management LLC acquired a new position in shares of Procter & Gamble during the second quarter worth $37,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Procter & Gamble
In other news, insider Marc S. Pritchard sold 9,849 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the completion of the sale, the insider directly owned 182,422 shares in the company, valued at $28,689,507.94. This trade represents a 5.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Andre Schulten sold 11,638 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,830,308.26. Following the transaction, the chief financial officer directly owned 52,642 shares in the company, valued at approximately $8,279,007.34. This trade represents a 18.11% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Trading Up 0.4%
Shares of PG stock opened at $151.98 on Tuesday. Procter & Gamble Company has a fifty-two week low of $146.96 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The stock has a 50 day simple moving average of $154.86 and a two-hundred day simple moving average of $158.59. The company has a market cap of $355.72 billion, a P/E ratio of 23.35, a PEG ratio of 4.02 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company's quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be issued a dividend of $1.0568 per share. The ex-dividend date is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble's dividend payout ratio is currently 64.82%.
Analyst Ratings Changes
A number of research firms recently weighed in on PG. BNP Paribas Exane decreased their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a report on Tuesday, September 23rd. Evercore ISI reissued an "in-line" rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Weiss Ratings restated a "hold (c+)" rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. JPMorgan Chase & Co. reduced their target price on Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating on the stock in a report on Friday, October 10th. Finally, UBS Group decreased their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research report on Wednesday, October 8th. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $171.68.
View Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.